📰 Genome Aggregation Database News
Genome Aggregation Database News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genome Aggregation Database. Real-time updates on events, politics, business and more.
May 1, 2024
Genetic characteristics that influence the risk of Parkinson's disease (PD) due to pesticide exposure.
December 8, 2023
Study presents a genome-wide map, "Gnocchi," constructed from 76,156 human genomes, revealing that non-coding regions rich in regulatory elements are crucial in understanding human traits and diseases.
August 14, 2023
Researchers explore the prevalence of rare genetic forms of obesity in a United Kingdom-based clinical obesity cohort.
June 13, 2023
The American College of Medical Genetics and Genomics (ACMG) has released updated recommendations for CFTR carrier screening. Pathogenic variants in the CFTR gene can cause cystic fibrosis (CF) as well as CF-related disorders. The new updated ACMG CFTR variant list includes a set of 100 variants.
December 20, 2022
Researchers in npj Genomic Medicine characterize autosomal recessive and X-linked genes in Genome Aggregation Database sequences, establishing an ancestry-specific pipeline validated in other cohorts.
December 5, 2022
- Article in Orphanet Journal of Rare Diseases estimates genetic prevalence of ENPP1 Deficiency at 1 in 64,000 pregnancies, more than tripling prior estimate - - Company estimates addressable patient... | December 5, 2022
December 1, 2022
AWS launches new service, Amazon Omics, to help bioinformaticians, researchers, and scientists store, query, and analyze genomic...
November 29, 2022
The cloud-based platform provides security, scale and the processing power needed for genomic data storage and analyses, eliminating the need for specialized infrastructure and workflows.
November 8, 2022
/PRNewswire/ -- Sentynl Therapeutics, Inc. ("Sentynl") a US-based biopharmaceutical company focused on bringing innovative therapies to patients living with...
November 8, 2022
/PRNewswire/ -- Sentynl Therapeutics, Inc. ("Sentynl") a US-based biopharmaceutical company focused on bringing innovative therapies to patients living with...